Qube Research & Technologies (QRT)’s ProShares Ultra Health Care RXL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-810	Closed	-$43K	–	4592
2024 Q1	$43K	Hold	810	–	–	﹤0.01%	3535
2023 Q4	$37K	Hold	810	–	–	﹤0.01%	3373
2023 Q3	$33.5K	Buy	+810	New	+$35.7K	﹤0.01%	2987
2022 Q4	–	Sell	-460	Closed	-$18K	–	2922
2022 Q3	$18K	Buy	460 +388	+539%	+$17.1K	﹤0.01%	2313
2022 Q2	$3K	Hold	72	–	–	﹤0.01%	2371
2022 Q1	$4K	Sell	72 -2,312	-97%	-$111K	﹤0.01%	2340
2021 Q4	$133K	Buy	2,384 +890	+60%	+$45.1K	﹤0.01%	2075
2021 Q3	$71K	Buy	1,494 +430	+40%	+$21.9K	﹤0.01%	1843
2021 Q2	$50K	Buy	+1,064	New	+$46.5K	﹤0.01%	2019

Other funds holding RXL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RXL Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of ProShares Ultra Health Care (RXL) in Q2 2024, closing a stake of 810 shares — an estimated $43K sold.

Qube Research & Technologies (QRT) first reported a position in RXL in Q2 2021 and held it in 9 quarters. The position peaked at $133K in Q4 2021. 17 funds tracked by Wall St. Rank hold RXL as of Q2 2024.

Qube Research & Technologies (QRT) reported no remaining ProShares Ultra Health Care position as of Q2 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 810 ProShares Ultra Health Care shares in Q2 2024, an estimated $43K.
Qube Research & Technologies (QRT) first reported a position in ProShares Ultra Health Care in Q2 2021 and held it in 9 quarters.
Qube Research & Technologies (QRT)'s ProShares Ultra Health Care position peaked at $133K in Q4 2021.
17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.